digital lecture series: chapter 08
DESCRIPTION
CONTENTS History Transmission of leprosy Etiopathogenesis Global and national scenario of leprosy Immunity and leprosy Microbiology of M.Leprae Classification of leprosy Clinical spectrum Systemic involvement in leprosy Differential diagnosis Diagnosis Treatment Lepra reactions Deformities Physiotherapy Prevention Rehabilitation in leprosy MCQs PhotoquizTRANSCRIPT
Digital Lecture Series: Chapter 08
Hansens Disease Digital Lecture Series: Chapter 08 Dr. Meghana
Phiske MD, DNB, DVD, DDV Assistant Professor Department of
Dermatology L.T.M.M.Cand L.T.M.G. HospitalSion, Mumbai CONTENTS
History Transmission of leprosy Etiopathogenesis
Global and national scenario of leprosy Immunity and leprosy
Microbiology of M.Leprae Classification of leprosy Clinical
spectrum Systemic involvement in leprosy Differential diagnosis
Diagnosis Treatment Lepra reactions Deformities Physiotherapy
Prevention Rehabilitation in leprosy MCQs Photoquiz History Oldest
infection known to mankind
India considered as point of origin of leprosy First written
reference appeared in Egyptian document written around 1550 BC Dr
Gerhard Henrik Armauer Hansen first described M.leprae to be the
causative organism in 1873. Synonyms: Hansens disease, Kushtha roga
Definition : Leprosy is a chronic systemic disease caused by
Mycobacterium leprae manifesting as development of specific
granulomatous or neurotrophic lesions in the skin, mucous membrane,
eyes nerves, bones and viscera. Transmission of Leprosy
Respiratory route : inhalation of bacilli-laden droplets Cutaneous
: skin to skin contact GIT : ingestion of food In utero
transmission Transmission through breast milk Intradermal :
inoculation by tattoos Incubation period : 5-7 years (on average)
Not Yet Proven Epidemiological Factors
Occurs at all age groups Peak age of onset : Between years
Males> Females (M:F: 2:1) (male predominance seen in adults, in
children gender distribution is nearly equal) Less common in
children and women Commonest type of leprosy in children :
Borderline tuberculoid Occurrence of disease depends on immune
status Genetic susceptibility reported Migration from rural to
urban areas: increase in cases Overcrowding, lack of personal
hygiene, humidity favor disease transmission Global & National
Scenario of Leprosy
Registered prevalence globally(2009) : Total cases detected in
India ( ) : 1.27 lakh Annual case detection rate in India : per one
lakh population Increased no of new case detected ( ): Orissa,
Gujarat,Maharashtra, Madhya Pradesh, Andhra Pradesh Immunity and
Leprosy Host resistance Excellent Good Fair Poor
Very poor Clinical manifestation No infection Subclinical infection
with spontaneousregression Indeterminate, pure neuritic,
tuberculoid Mid-borderline, borderline-lepromatous Lepromatous
Immunopathogenesis of leprosy
Entry of M.Leprae in the body via nose Invasion Multiplication in
dermal lymphatics and vascular endothelial cells Hematogenous
spread Invasion of M.Leprae into nerves Immunological response
Mycobacterium Leprae Obligate, non motile, nonspore forming
microaerophilic intracellular, acid-fast bacillus that forms curved
or straight rods Components include : Cell wall, cell membrane,
cytoplasm and capsule Affinity for skin, nerves and muscle tissue
Found in macrophages, histiocytes and Schwann cells Non cultivable
Grown in animal models(armadillo and mice) Closely resembles M.
Tuberculosis, but less acid-fast. Multiplies (generation time) in
days Classification Ridley Jopling classification Indeterminate
Tuberculoid
Borderline borderline-tuberculoid mid-borderline
borderline-lepromatous Lepromatous Classification Indian
Classification Lepromatous Tuberculoid
Maculoanesthetic Borderline Pure neuritic Indeterminate
Classification NLEP Classification Nonlepromatous Tuberculoid
Maculoanesthetic Polyneuritic Indeterminate Borderline Lepromatous
Tuberculoid (TT) Single or few (upto 3), large,dry, asymmetrical,
erythematous / hypopigmented patches withwell-defined margins.
Sweating Lost Sensations Absent Nerves - Thickened, presence of
feeding nerves,abscesses Skin smears Negative Lepromin test -
Strongly positive Course-Polar TT stable and sub polar TT may
downgrade. Borderline Leprosy Common type of leprosy Subdivided
into BT, BB & BL.
Course - Unstable with variable prognosis, may progress to
sub-polar LL leprosy. Most prone to reactions. Lepromin test
-Negative, weakly positive in BT. Borderline Tuberculoid (BT)
Few(upto 10),large, asymmetric, hypopigmented or skin coloured
macules, plaques with ill defined margins Surface-Dry with hair
loss Presence of satellite lesion near the advancing margin of
patch Sensory impairment - Marked Nerve involvement-Irregular and
asymmetrical Deformities are common Lepromin test-Weakly positive
Satellite lesion Borderline tuberculoid leprosy Midborderline
leprosy (BB)
Unstable form, reactions frequent Multiple and symmetric lesions
Lesions range from papules, macules and plaques Plaques show well
demarcated edges with characteristic punched out centre (inverted
saucer shaped) Face may show infiltration with nodules on ears
Sensory impairment - Moderate. Nerve involvement-Many nerves
involved and asymmetrical Borderline lepromatous leprosy (BL)
This type classically start as macule, widespread and symmetrical,
later become infiltrated centrally Papules, nodules and plaques
with sloping edges Sensory impairment- Variable (more in centre)
Nerve involvement - Widespread andasymmetrical Glove & stocking
hypoaesthesia occurs late Lepromin reaction-Negative
Prognosis-Variable Lepromatous leprosy Lesions symmetrically
distributed, small, multiple, shiny and waxy. Macular, infiltrated,
nodular, diffuse or ulcerative Macules-Small, widespread, ill
defined margins Nodules- Arise from macules or infiltrated lesions
Sensory impairment-Normal or mild Leonine facies- Infiltration of
skin with nodules, loss of eyebrows and eyelashes. Nerve
involvement -Symmetrical, not markedly enlarged, fibrotic and
shrunken in late stages. Glove and stocking anaesthesia Lepromin
test - Negative Ear infiltration in lepromatous leprosy
Indeterminate leprosy
Commonest presentation in children (20-80%) Flat erythematous or
hypopigmented, asymmetrical, macules varying in number, size and
location with vague margins Common sites : Face, limbs, thighs
Sensation - Normal or slightly impaired Peripheral nerves - Normal
Skin smears - Negative Lepromin test - Unpredictable and variable
Course - Usually self limiting, may progress to other forms of
leprosy. Pure Neuritic leprosy Commonly reported from India and
Nepal
Male preponderance seen Sensory loss without skin lesion Neuritic
manifestations -Tingling, heaviness and numbness, paresis,
hypotonia, atrophy, claw hand and toes, wrist-drop, foot-drop.
Other changes-Anhidrotic, dry glossy skin, blisters, neuropathic
ulcers, decalcification, bone resorption Dry skin in leprosy Pure
Neuritic leprosy Lepromin test -Slightly positive
Course-Spontaneous regression or progression to TT leprosy Silent
neuritis (silent neuropathy) Sensory or motor impairment without
skin signs of reversal reaction or ENL, tenderness, paresthesia or
numbness Special forms of Leprosy
Lucio Leprosy/Lepra Bonita/Beautifulleprosy Rare form of
lepromatous leprosy, described in Mexico. Diffuse widespread
infiltration of skin, loss of body hair, loss of eyebrows &
eyelashes, and widespread sensory loss. Histoid leprosy Seen in LL,
but also in borderline and indeterminate cases. Seen in patients
taking irregular or inadequate treatment and in drug resistant
cases. Nodulesare firm, reddish or skin colored, dome shapedwith
shinyskin. Skin smears- Many bacilli seen. Lazarine leprosy Diffuse
ulceration seen as a part of lepra reaction in undernourished
patients. Histoid leprosy Eye Involvement in Leprosy
Eyebrows/eyelashes-Madarosis, trichiasis leading to corneal
vascularity and opacity Facial nerve palsy- Lagophthalmos
(partial/complete, unilateral/bilateral) and ectropion Trigeminal
nerve palsy-Exposure keratitis and vision loss Lacrimal gland-Dry
eye and Dacryocystitis (acute, subacute or chronic) Cornea-
Enlarged nerves, ulcers, lepromata, punctate keratitis and pannus
Sclera-Nodules on sclera, scleritis and episcleritis Uvea-
Granulomatous and chronic uveitis Iris-Iris pearls Lens-Cataract
Retina-Impaired contrast sensitivity Nerve Involvement in
Leprosy
Sensory involvement - Anaesthesia in hands & feet, glove and
stocking anaesthesia, repeated trauma Motor involvement- Wasting
and paralysis of muscles Autonomic involvement - Ichthyosis, loss
of hair and sweating Other features Nose : Nasal stuffiness /
crusting, epistaxis, nasal deformity (Saddle nose) Ear :
Infiltration/nodules, ulceration Liver : Lepromatous
hepatitis,amyloidosis Hoarseness of voice Gynaecomastia Bone
resorption Lymphadenopathy Differential Diagnosis
Macular lesions (hypopigmented) Vitiligo Occupational leucoderma
Tinea versicolor Pityriasis alba Post kala azar dermal
leishmaniasis Naevus depigmentosus and nevus anemicus
Postinflammatory hypomelanosis Polymorphic light eruption
Differential Diagnosis
Macular lesions (erythematous) Pityriasis rosea Seborrhoeic
dermatitis Tinea incognito Secondary syphilis Differential
diagnosis of hypopigmented conditions
Post kala azar dermal leishmaniasis Vitiligo vulgaris P. Alba
Differential diagnosis of hypopigmented conditions
Polymorphus light eruption P. Versicolor Differential
Diagnosis
Annular lesions Anular psoriasis Erythema multiforme Granuloma
annulare Sarcoidosis Infiltrated lesions Lupus vulgaris Lupus
erythematosus Annular syphilides Post kala azar dermal leismaniasis
(infiltrated lesions) Psoriasis Differential diagnosis of annular
lesions
Lupus vulgaris Psoriasis vulgaris Differential diagnosis of annular
lesions
Granuloma Annulare Tinea Corporis Annular Syphillis Nodular Lesions
Post kala azar dermal leismaniasis
Cutaneous leishmaniasis Syphilis Sarcoidosis Leukaemia cutis
Mycosis Fungoides Nodules of neurofibromatosis Kaposis sarcoma
Tuberous sclerosis Differential diagnosis of nodular lesions
Neurofibromatosis Leukemia Cutis Differential diagnosis of
neurological conditions
Sensory impairment with or without muscle wasting Peripheral
neuropathy Diabetic neuropathy Primary amyloidosis of peripheral
nerves Congenital sensory neuropathy Syringomyelia Tabes dorsalis
Thoracic outlet syndrome Alcoholic neuropathy Hereditary motor and
sensory neuropathy Diagnosis Cardinal signs of leprosy Anesthetic
skin lesions
Nerve enlargement Demonstration of M.Leprae Only one of these three
features needed to make diagnosis Clinical Examination Detailed
history
Number of skin lesions : >10, 10-15, or numerous Distribution
Size Colour : Hypopigmented / erythematous / coppery Shape :
Circular, oval, irregular, annular Morphology : Macule / patch /
plaque / papule / nodule Margin : Raised / flat, well / ill
defined, sloping / punched out Surface : dry, scaly, smooth, shiny,
edematous, ulcerated Clinical Examination Symmetrical
appearance
Cutaneous nerve twig over the patch Earlobe infiltration Sensory
impairment Motor examination Nerve examination Trophic ulcers
Gynecomastia Loss of hair / sweating Clinical Examination Sensory
Touch : Tested with wisp of cotton
Temperature : Tested with two test tubes one containing hot water
and other cold Pain : Tested by pin prick Semmes-Weinstein
monofilament testing Corneal reflex : Tested with a wisp of sterile
cotton wool Motor Testing of motorpower- Done clinically
Electro-diagnosis - Employed in very early cases. Electrical
stimulator using faradic and galvanic current used to test muscle
power Monofilaments Nerve Examination Check for enlargement,
tenderness,nodularity and abscess and scoring system Scoring system
for enlarged nerves Normal 0 Enlarged + Moderately enlarged ++ Very
much enlarged +++ Nerves Supra/ infraorbital Greater auricular
Ulnar Median Radial
Lateral popliteal Anterior/posterior tibial Sural Cutaneous branch
ofradial nerve Enlarged greater auricular nerve Investigations for
M. Leprae
Bacteriological examination Skin smears : Made by slit and scrape
method from the most active looking edge of skin lesion and stained
with Ziehl-Neelsen method. Reading of smears : Bacteriological
index - Indicates density of leprosy bacilli (live & dead) in
the smears and ranges from 0 to 6+ Morphological index - It is the
percentage of presumably living bacilli in relation to total number
of bacilli in the smear Other Investigations Histopathological
examination Nerve biopsy
Sweat function test Nasal mucosal smears Histamine tests Lepromin
test FNAC Animal Models : Armadillo, Thymectomised, irradiated nude
mice, Korean chipmunk etc. Newer Investigations Serological assays:
FLA-ABS, RIA, ELISA PGL, PCR
Other techniques: Chemical, Immunological, Molecular biological,
Bioluminescent techniques, Strain specific probes Indications : To
confirm diagnosis in c/o inconclusive histopathological/smear
reports. To distinguish between reaction and relapse To demonstrate
M. leprae or its components To elicit strain differentiation for
molecular epidemiology To detect drug susceptibility or resistance
Treatment MDT-WHO Paucibacillary leprosy (6 months)
Cap. Rifampicin (600 mg) monthly, supervised Tab. Dapsone (100 mg)
daily Multibacillary leprosy (1 year) Cap. Rifampicin (600mg)
monthly, supervised Cap. Clofazimine (300mg) monthly, supervised
Tab. Dapsone (100mg) daily Cap. Clofazimine (50mg) daily Blister
packets for MDT
Easy to use, handy and of convenient size Provide complete
treatment Improve clinical attendance Drugs are better protected
against moisture, heat and accidental damage Ensures quicker
dispensing of the drugs Can be dispensed by non medical person
Blister Packets Other New Regimens ROM Rifampicin - 600 mg
Ofloxacin - 400 mg,
Minocycline - 100mg Single dose - Single patch (WHO accepted) ROM-6
(Monthly for 6 months)-Paucibacillary ROM-12(Monthly for 12
months)-Multibacillary Ofloxacin based regimes RO (continuous
treatment for 28 days) ROM trial (intermittent therapy)
Moxifloxacin based regimes Immunomodulatory Drugs
Drugs - Levamisole, Zinc Antigenically related mycobacteria B.C.G
vaccine M.leprae +B.C.G vaccine Mycobacterium welchii vaccine ICRC
vaccine Other immunomodulators-Gamma interferons, interleukins
Newer Drugs / Regimens Fluoroquinlones (eg pefloxacin, ofloxacin,
sparfloxacin, moxifloxacin) Minocycline Macrolides (Clarithromycin)
Ansamycin- Rifabutin, rifapentine ,isobutylpiperazinyl rifampicin,
R-76-1 Cephalosporins Beta lactamase inhibitors Fusidic acid
Dihydrofolate reductase inhibitors-Brodimoprim, epiroprim Hydrozone
derivaties-PH-22 and PQ-22 Deoxy-Fructo-Serotonin Lepra Reactions
Acute episodes or bouts of exacerbations occurring in course of
chronic disease It is a sudden tissue response resulting from
liberation of bacilli or their products into the tissues,
manifestations of which are local or systemic Sudden increase in
activity of existing lesions, appearance of fresh lesions with or
without constitutional symptoms Type I reaction - All borderline
cases (BT, BB,BL) Type II reaction -LL and sometimes BL cases
Precipitating Factors
Pregnancy / lactation Drugs-Antileprosy drugs, iodides Severe
physical or mental stress, surgical stress Infections Alcohol Type
I Reaction Type IV hypersensitivity reaction Sub - types
Upgrading (Reversal) Downgrading Existing lesions worsen / New
lesions may appear (have typical characteristic of TT leprosy)
Lesions become erythematosus and / or edematous and may ulcerate
Neuritis / Nerve abscesses Systemic disturbances - Unusual Type I
Reaction Diagnosis : Clinical, histopathology (epitheloid cell
granuloma, dermal edema, plasma cells and foreign body giant cells)
Complications : Neuritis, dactylitis, edema of hands/ feet, corneal
anesthesia, conjunctivitis, sudden occurrence of claw hand,
foot-drop, facial palsy Type I reaction with enlarged nerve and
nerve abscess Type II Reaction (ENL-erythema nodosum
leprosum)
Occurs in BL and LL cases Type III hypersensitivity reaction Crops
of tender, warm, recurrent, evanescent, erythematous nodules
distributed bilaterally symmetrically located on thighs ,legs and
face Vesicular lesions can occur which break down to form ulcers
(erythema necroticans) ENL precedes fever, malaise, headache
andjoint pains Other manifestations : Rhinitis, epistaxis,
Iridocyclitis, episcleritis, dactylitis, epididymo-orchitis,
arthritis, neuritis, bone pain and lymphadenitis Diagnosis :
Clinical, slit skin smears show broken bacilli, biopsy (vasculitis)
ENL and necrotic ENL Type II Reaction - complications
Frozen hand Laryngitis Non-paralytic deformity Polyarthritis /
RA-like syndrome Multiple dactylitis Leucocytosis, anaemia, raised
ESR Albuminuria / nephrotic syndrome Liver / spleen enlargement
Epididimytis / orchitis, testicular atrophy / sterility
Gynaecomastia Adrenal gland hypofunction Eye involvement Type 3
reaction (Lucio phenomenon)
Rare form of reaction observed only in Lucio leprosy Acute ,severe,
necrotizing vasculitis occurring in patients of Mexican ancestry
Presents as painful erythematosus patches that become necrotic and
ulcerated Treatment of Lepra reactions Principles of treatment
Early initiation of treatment for reaction Continuation /
initiation of MDT Removal of precipitating factor Rest, physical
and mental Treatment Modalities Mild reaction Analgesics (aspirin
or paracetamol)
Severe reaction Corticosteroids Antimalarials Clofazimine
Thalidomide Methotrexate Cyclosporine Azathioprine Mycophenolate
mofetil Treatment Modalities Supportive management
Surgical decompression of nerves, splints / padding, treatment of
steroids / atropine eye drops for iridocyclitis, steroids / scrotal
support for epipdidymoorchitis Newer drugs for ENL : Leukotriene
inhibitors, thalidomide derivatives, infliximab
Deformities/Disabilities in leprosy
Deformity : Visible alteration in the appearance which results in
disability. Disability : Restriction or lack of ability to perform
an activity considered normal for a human. Primary : Are caused by
the tissue reaction to infection with M.Lepra e.g. leonine facies,
flat-nose, claw hand. Secondary : Occur as a result of damage to
the anesthetic parts of the body e.g. planter ulcers, corneal
ulcers. Grading of Deformities/Disabilities : WHO disability
grading
Grade 0 : No anaesthesia, no visible deformity or damage in hands
and feet, or no problems in eye or no visual loss. Grade 1 :
Anaesthesia present, but no visible deformity or damage, eye
problems due to leprosypresent but vision not severely affected
(6/60 or better) and can count fingers at 6 metres. Grade 2 :
Visible deformity or damage present in hands or feet , and severe
visual impairment (vision worse than 6/60)i.e unable to count
fingers at 6 metres or lagophthalmos or iridocyclitis or corneal
opacities. Deformities Primary Deformities Leonine facies
Loss of eyebrows and eyelashes Depressed nose Gynaecomastia Palatal
perforation Secondary deformities Corneal ulcers and opacities
Plantar ulcers Palmar ulcers and ulcers on tips of fingers
Resorption Charcot joints Plantar ulcer Deformities : Nerve
Damage
Claw hand (ulnar, median) Clawing of the toes (posterior tibial)
Wrist-drop (radial) Foot-drop (lateral popliteal) Lagophthalmos,
facial palsy (facial) Trophic Ulcer : Stages Threatened ulcer :
Process of tissue damage starts associated with inflammation
Presents as edemaand warmth in region of metatarsal head with
associated deep tenderness and increase in inter digital gap
Concealed ulcer : Damage to subcutaneous tissue presents asnecrosis
and blisters at the site of damage Open ulceration : Skin breaks
down and tissue damage site is exposed to form frank ulcer Types of
ulcers : Acute ulcer/ Chronic ulcer Complicated/uncomplicated ulcer
Prevention of Deformities
Adequate treatment of leprosy patient Early detection of nerve
damage Prevention of nerve damage Protection of anesthetic hands
from injury Care of hands with weakness/paralysis Use of protective
footwear Adequate hydration of skin Physiotherapy Management of
Deformities
Education of patient regarding prevention of injuries Daily
examination of hands and feet and prompt treatment for minor
injuries Using adapted tools and appliances after training
Reconstructive surgery Rehabilitation Physiotherapy Oil massage/Wax
Therapy-Uses
To make the skin soft and supple and loosen stiff joints As a
preliminary to exercises To strengthen muscles and keep joints
mobile To reduce pain in acute neuritis To stimulate innervated
sweat glands to increase blood flow Exercises : Active and assisted
exercise : To increase the strength of muscles and retain their
tone Electric stimulation Uses To maintain the tone of denervated
muscle Helpful in breaking post operative adhesions Beforetendon
surgery could be used as a means ofdocumenting nerve damage and the
progress of the nerverecovery with treatment. Splints Indication
Acute neuritis
Mobile deformities(to prevent fixed deformities), Fixed
deformities(to correct the deformities). Various splints For radial
neuritis-Static or dynamic wrist drop splint For mobile deformity-
Static or dynamic splint For fixed deformity-Gutter splints, finger
loops etc. Splints for various deformities Hand deformities :
Gutter splints, finger loop splints, opponens splints and adductor
bands Foot deformity : Y strap with spring, single elastic strap
Prevention and Control of leprosy
Prevention of leprosy Early detection through survey and initiation
oftreatment Families of patients to be kept under surveillance
Immunoprophylaxis -Use of leprosy vaccines Improvement in
socio-economic conditions Leprosy control Three activities of a
leprosy control unit Case detection Case holding, including
treatment Health education of public and patients Prevention and
Control of leprosy
Leprosy Organizations UNICEF LEPRA, DANIDA, SIDA, CIDA, Leprosy
mission, American leprosy mission (ALM), German leprosy relief
association(GLRA), LEPRA, Netherland leprosy relief (NLR) Leprosy
control Programmes National leprosy control programme (NLCP) 1954
Triad of Survey, Education and Treatment (S.E.T). National leprosy
eradication programme (NLEP) 1982 Prevention and Control of
leprosy
National Leprosy Eradication Programme (NLEP), 1982 Eradicate
leprosy from the country by 2000. Vertical health programme- In
areas where prevalence of leprosyis more than 5 per 1000.
Horizontal programme- In areas where the prevalence rate is less
than 5 per 1000. Three main units for programme operation : Basic
tier : Survey, education and treatment unit, leprosy control unit
and urban leprosy control unit. Second tier : District/zonal
leprosy office. Third tier : Leprosy division of the state
Directorate of the health services. Rehabilitation in Leprosy
Physical and mental restoration of patients to normal activities,
sothat they are able to assume their place in the home, society and
industry. Treatment of physical disability Education of patient,
family and public Rehabilitation in special homes or institutional
rehabilitation Community based rehabilitation MCQS Q.1) What is the
incubation period of leprosy? 1-10 yrs
Q.2) When was National leprosy eradication programme (NLEP)
started? 1982 1983 1984 1985 Ans : Q. 1 A, Q. 2 A MCQS Q.3) What is
the generation time of leprosy? 1-10 days
Q.4) Satellite lesion is commonly seen in which type of leprosy?
Indeterminate Lepromatous Borderline tuberculoid Tuberculoid Ans :
Q. 3 B, Q. 4 C MCQS Q.5) Cardinal signs of leprosy include all
except
Anesthetic lesions Enlarged Nerves Demonstration of M. Leprae
Trophic ulcer Q.6) What is the duration of multi-bacillary
treatment? 6 Months One Year Two Years Three Years Ans : Q. 5 D, Q.
6 B Photo Quiz Ans : Claw hand caused by affection of ulnar nerve A
14 year old boy presented with a flexion of interphalangeal joints
of little and ring finger? What is the deformity and which nerve
causes it? Photo quiz Ans : Borderline tuberculoid leprosy A 15
year old boy presented with multiple asymptomaticlesions with
asymmetric enlargedulnar nerve. What is the likely diagnosis? Photo
Quiz Ans : Vitiligo vulgaris, P. alba A 4 year old girl presented
with aysmptomatic non scaly, whitish patch with intact sensations.
What is the likely differential diagnosis? Thank You!